Home › Funds › CPP Investments › RPRX
CPP Investments position in RPRX
ROYALTY PHARMA PLC · Health Care
Latest position (Q2 2026)367.81K sh
Reported value held$20.62M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 134.17K | $4.85M | New |
| Q4 2021 | 102.41K | $4.08M | Reduce |
| Q1 2022 | 113.25K | $4.41M | Add |
| Q2 2022 | 108.66K | $4.57M | Reduce |
| Q3 2022 | 139.66K | $5.61M | Add |
| Q4 2022 | 4.55K | $180.01K | Reduce |
| Q1 2023 | 472.50K | $17.02M | Add |
| Q2 2023 | 660.20K | $20.29M | Add |
| Q3 2023 | 742.20K | $20.14M | Add |
| Q4 2023 | 877.80K | $24.66M | Add |
| Q1 2024 | 923.64K | $28.05M | Add |
| Q2 2024 | 784.57K | $20.69M | Reduce |
| Q3 2024 | 766.54K | $21.69M | Reduce |
| Q4 2024 | 805.62K | $20.55M | Add |
| Q1 2025 | 654.00K | $20.36M | Reduce |
| Q2 2025 | 569.20K | $20.51M | Reduce |
| Q3 2025 | 10 | $353 | Reduce |
| Q4 2025 | 14.71K | $568.39K | Add |
| Q1 2026 | 49.31K | $2.37M | Add |
| Q2 2026 | 367.81K | $20.62M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RPRX
- Morgan Stanley 42.93M sh · $2.41B · Q2 2026
- BlackRock Inc 27.83M sh · $1.56B · Q2 2026
- Fidelity Management & Research (FMR) 24.51M sh · $1.37B · Q2 2026
- Baillie Gifford & Co 10.02M sh · $561.57M · Q2 2026
- Capital World Investors 9.52M sh · $533.64M · Q2 2026
- Geode Capital Management 8.06M sh · $450.58M · Q2 2026
- Vanguard Group 9.93M sh · $383.87M · Q4 2025
- Norges Bank Investment Management 5.34M sh · $299.19M · Q2 2026
- Northern Trust Corp 4.72M sh · $264.59M · Q2 2026
- AQR Capital Management 4.31M sh · $241.40M · Q2 2026
- Invesco Ltd 4.23M sh · $237.32M · Q2 2026
- Bank of America Corp 4.15M sh · $232.66M · Q2 2026